David J. Lederer
Impact in
- Pulmonary and Respiratory Medicine top 0.05%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pulmonary Hypertension Research and Treatments
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Medical Imaging and Pathology Studies
- Occupational and environmental lung diseases
- Transplantation top 0.5%
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 67
- Pulmonary Hypertension Research and Treatments 21
- Chronic Obstructive Pulmonary Disease (COPD) Research 17
- Neonatal Respiratory Health Research 12
- Surgery 69
- Transplantation: Methods and Outcomes 62
- Organ Transplantation Techniques and Outcomes 18
- Co-authors
- Fernando J. Martínez (8 shared papers)Steven D. Nathan (15 shared papers)Steven M. Kawut (66 shared papers)Selim M. Arcasoy (52 shared papers)Marilyn K. Glassberg (13 shared papers)Lisa Lancaster (13 shared papers)Ian Glaspole (12 shared papers)Jeffrey J. Swigris (12 shared papers)
- Journals
- CHEST Journal (25 papers)The Journal of Heart and Lung Transplantation (21 papers)American Journal of Transplantation (15 papers)American Journal of Respiratory and Critical Care Medicine (15 papers)Annals of the American Thoracic Society (15 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
David J. Lederer
223 papers receiving 13.8k citations
David J. Lederer's Hit Papers
Peers
Comparison fields: 5 of 162
- Pulmonary and Respiratory Medicine 9.0k
- Transplantation 402
- Physiology 2.1k
- Surgery 2.7k
- Geriatrics and Gerontology 127
Countries citing papers authored by David J. Lederer
This map shows the geographic impact of David J. Lederer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Lederer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Lederer more than expected).
Fields of papers citing papers by David J. Lederer
This network shows the impact of papers produced by David J. Lederer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Lederer. The network helps show where David J. Lederer may publish in the future.
Co-authors
The 25 scholars most cited alongside David J. Lederer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 231 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2014 | 2739 |
| 2 | Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2018 | 1362 |
| 3 | A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation Hit paper breakdown → | 2014 | 901 |
| 4 | Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial Hit paper breakdown → | 2019 | 411 |
| 5 | Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan Hit paper breakdown → | 2013 | 401 |
| 6 | Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials Hit paper breakdown → | 2015 | 338 |
| 7 | Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading Hit paper breakdown → | 2011 | 332 |
| 8 | 2006 | 325 | |
| 9 | Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung Function Hit paper breakdown → | 2019 | 265 |
| 10 | 2016 | 254 | |
| 11 | 2011 | 223 | |
| 12 | 2019 | 223 | |
| 13 | 2019 | 203 | |
| 14 | 2009 | 201 | |
| 15 | 2007 | 195 | |
| 16 | 2010 | 193 | |
| 17 | 2019 | 179 | |
| 18 | 2016 | 135 | |
| 19 | 2017 | 132 | |
| 20 | 2018 | 123 |
About David J. Lederer
David J. Lederer is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Physiology, Epidemiology and Immunology, having authored 231 papers that have together received 14.1k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (67 papers), Transplantation: Methods and Outcomes (62 papers), Asthma and respiratory diseases (26 papers), Pulmonary Hypertension Research and Treatments (21 papers), Organ Transplantation Techniques and Outcomes (18 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers), Neonatal Respiratory Health Research (12 papers) and IL-33, ST2, and ILC Pathways (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (9.0k citations), Transplantation (402 citations), Physiology (2.1k citations), Surgery (2.7k citations) and Geriatrics and Gerontology (127 citations). David J. Lederer has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Fernando J. Martínez, Steven D. Nathan, Steven M. Kawut, Selim M. Arcasoy, Marilyn K. Glassberg, Lisa Lancaster, Ian Glaspole, Jeffrey J. Swigris, Williamson Z. Bradford and Carlos A. Pereira. Their work appears in journals such as CHEST Journal, The Journal of Heart and Lung Transplantation, American Journal of Transplantation, American Journal of Respiratory and Critical Care Medicine and Annals of the American Thoracic Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.